Catalyst Wire Dossier Catalyst Wire Dossier

23-valent pneumococcal polysaccharide vaccine

Pneumococcal polysaccharide vaccine 23-valent · Ab&B Bio-tech Co., Ltd
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for 23-valent pneumococcal polysaccharide vaccine, covering 2012-09-05 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above [Phase 1]

See pricing